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Enhancement of MSH2–MSH3-mediated mismatch recognition
by the yeast MLH1–PMS1 complex
Yvette Habraken, Patrick Sung*, Louise Prakash and Satya Prakash
DNA mismatch repair has a key role in maintaining
genomic stability. Defects in mismatch repair cause
elevated spontaneous mutation rates and increased
instability of simple repetitive sequences, while
mutations in human mismatch repair genes result in
hereditary nonpolyposis colorectal cancers [1,2].
Mismatch recognition represents the first critical step
of mismatch repair. Genetic and biochemical studies in
yeast and humans have indicated a requirement for
MSH2–MSH3 and MSH2–MSH6 heterodimers in
mismatch recognition. These complexes have, to some
extent, overlapping mismatch binding specificities
[3–10]. MLH1 and PMS1 are the other essential
components of mismatch repair, but how they function
in this process is not known. We have purified the yeast
MLH1–PMS1 heterodimer to near homogeneity, and
examined its effect on MSH2–MSH3 binding to DNA
mismatches. By itself, the MLH1–PMS1 complex shows
no affinity for mismatched DNA, but it greatly enhances
the mismatch binding ability of MSH2–MSH3. 
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Results and discussion
The MLH1 protein was overexpressed in yeast by placing
the MLH1 gene under the control of the ADCI promoter,
to give plasmid pMMR75. To overexpress the PMS1
protein in yeast, we fused the PMS1 gene to the galactose-
inducible GAL-PGK promoter, yielding plasmid pMMR97.
The overproduction of MLH1 and PMS1 proteins in yeast
cells harboring these plasmids was verified by Western
analyses using affinity-purified antibodies specific for
these proteins (Figure 1a). 
The MLH1 and PMS1 proteins combine to form a stable
complex, which was purified from the protease-deficient
yeast strain LY2 harboring both pMMR75 and pMMR97
(see Materials and methods). Fraction VII MLH1–PMS1
complex from the last step of purification in Mono Q was
highly purified, as judged by Coomassie blue staining of a
7.5% denaturing polyacrylamide gel (Figure 1b).
Throughout purification, no dissociation of the
MLH1–PMS1 complex was evident in column fractions
containing as little as 4 × 10–9 M of the complex, indicat-
ing a dissociation constant of the complex at or below this
protein concentration. Densitometric scanning of the
polyacrylamide gel containing purified MLH1–PMS1
complex indicated a one-to-one stoichiometry of the two
proteins in the complex. 
As both MLH1 and PMS1 are indispensable for mismatch
repair [1,2], we examined purified MLH1–PMS1  for DNA
mismatch recognition activity. We hybridized oligonu-
cleotides to form either a homoduplex or duplexes that
contained a G/T mismatch or an extrahelical loop of
varying size (Figure 2a), and used gel mobility shift in
polyacrylamide gels [7] to examine whether purified
MLH1–PMS1 binds the DNA mismatches. With the
homoduplex and the +4 DNA substrate, except for a slight
smearing of the DNA probes, which suggests a low level of
non-specific binding, no stable nucleoprotein complex of
the DNA probes and MLH1–PMS1 was detected (Figure
2b). Similar results were obtained with DNA substrates
that contained a G/T mismatch (G/T), a one-base loop
(+1), and a two-base loop (+2) (data not shown). These
observations indicated that MLH1–PMS1 protein complex
by itself does not possess mismatch binding activity.
In addition to MLH1 and PMS1, mismatch repair also
requires other proteins, including MSH2, MSH3, and
MSH6. MSH2 and MSH3 [7] and MSH2 and MSH6 [6]
combine to form stable one-to-one complexes. We have
purified the MSH2–MSH3 complex to near homogeneity
from a yeast strain genetically tailored to overexpress the
two proteins [7]. As demonstrated previously and reiterated
in this work, purified MSH2–MSH3 binds specifically to
DNA fragments containing extrahelical loops [7] (Figure 2).
As shown previously, purified MSH2–MSH3 contains three
electrophoretically separable forms of MSH3 [7]. The dif-
ferent shifted bands seen with MSH2–MSH3 (Figure 2b)
may represent nucleoprotein complexes of these MSH3
forms. We investigated whether the addition of
MLH1–PMS1 would impact upon the mismatch recogni-
tion properties of MSH2–MSH3. A much higher level of
the +4 DNA substrate was converted to slower migrating
forms when it was incubated with both MLH1–PMS1 and
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MSH2–MSH3 than when it was incubated with
MSH2–MSH3 alone (Figure 2b,c). In constrast, binding of
the homoduplex in the presence of both MLH1–PMS1 and
MSH2–MSH3 was no higher than the background level
seen with MSH2–MSH3 alone (Figure 2b). Thus, it
appears that MLH1–PMS1 specifically enhances the mis-
match binding ability of MSH2–MSH3.
We showed previously that higher levels of nucleoprotein
complexes are formed between the DNA substrate and
MSH2–MSH3 when the size of the extrahelical loop is
increased [7]. As MLH1–PMS1 exerts a remarkable stimu-
latory effect on the ability of MSH2–MSH3 to bind the
DNA substrate containing a +4 loop, we wished to deter-
mine whether the former would also enhance the binding
of MSH2–MSH3 complex to substrates containing smaller
extrahelical loops and a G/T mismatch. Figures 2d and 2e
indicate that MLH1–PMS1 stimulates the binding of
MSH2–MSH3 to substrates containing a +2 loop and a +1
loop to about the same extent as the stimulation seen with
the substrate that contains a +4 loop. The G/T mismatch is
bound poorly by the MSH2–MSH3 heterodimer, but
MLH1–PMS1 also has some stimulatory effect on this
binding. Thus, MLH1–PMS1 positively regulates the mis-
match binding activity of MSH2–MSH3 regardless of the
nature of the mismatch, but it does not alter the binding
specificity of the latter. 
To verify that MLH1 and PMS1 were part of the ternary
nucleoprotein complex, we carried out supershifting
experiments with anti-MLH1 and anti-PMS1 antibodies
using the +4 loop substrate. The nucleoprotein complex
formed in the presence of MSH2–MSH3/MLH1–PMS1
has a retarded mobility (Figure 2f, lane 3) compared to
the nucleoprotein complex formed with the
MSH2–MSH3 heterodimer alone (lane 1). Treatment of
the ternary complex with anti-MLH1 or anti-PMS1 anti-
bodies results in supershifting (Figure 2f, lanes 4 and 5),
indicating the presence of MLH1–PMS1 heterodimer in
this complex. As expected, neither anti-MLH1
(Figure 2f, lane 2) nor anti-PMS1 antibodies (data not
shown) affect the mobility of the nucleoprotein complex
formed with MSH2–MSH3.
We investigated whether the addition of ATP would have
any effect on mismatch binding effected by the
MSH2–MSH3 and the MLH1–PMS1 complexes (see
Supplementary material). The inclusion of 1 mM ATP or
ATPγS, however, has no detectable effect on binding of
the +4 substrate by MSH2–MSH3 alone, by
MLH1–PMS1 alone, or by the mixture of MSH2–MSH3
and MLH1–PMS1 (data not shown). The same results
were obtained with the homoduplex, the G/T substrate,
and the substrates containing the +1 loop and the +2 loop
(data not shown). This insensitivity to ATP contrasts with
the marked reduction in MSH2–MSH6 mismatch binding
in the presence of ATP [6,9]. The reason for this differen-
tial sensitivity to ATP remains to be determined.
Even though MSH2 can bind DNA mismatches [11],
MSH2 has a much lower affinity for mismatch-containing
DNA substrates compared with the MSH2–MSH3
complex [7]. This is consistent with genetic studies sug-
gesting that MSH2–MSH3 and MSH2–MSH6 are the
physiologically relevant species in mismatch recognition
[4,5]. To verify this, we examined whether the
MLH1–PMS1 complex affects mismatch binding by
MSH2. In contrast to the strong stimulatory effect of
MLH1–PMS1 on mismatch binding by MSH2–MSH3, no
stimulation of binding of the +4 substrate was seen when
MLH1–PMS1 was incubated with MSH2 (see Supple-
mentary material); the same results were obtained with
the +1, +2, and G/T substrates (data not shown). 
Even though the MLH1–PMS1 complex shows no affin-
ity for DNA mismatches, it dramatically enhances the mis-
match binding ability of MSH2–MSH3. Thus, our studies
provide evidence of a new role for the MLH1–PMS1 het-
erodimer in mismatch recognition. Human MutLα, which
is a heterodimer of MLH1 and PMS2 (equivalent to yeast
PMS1), has been purified previously [12], but the effect of
hMutLα on mismatch binding by MSH2–MSH3 has not
been examined. The high degree of evolutionary conser-
vation of mismatch repair proteins in eukaryotes would
predict a similar role for hMutLα in mismatch binding.
Our results also suggest a similar stimulatory role for
MLH1–PMS1 on MSH2–MSH6 mismatch binding.
Figure 1
(a) Overexpression and purification of MLH1-PMS1 complex.
Nitrocellulose blot of a 7.5% denaturing polyacrylamide gel probed
with anti-MLH1 and anti-PMS1 antibodies. Lane 1, extract from LY2
harboring the MLH1 overproducing plasmid pMMR75; lane 2, extract
from LY2 harboring the PMS1 overexpressing plasmid pMMR97; lane
3 extract from LY2 harboring both pMMR75 and pMMR97. 
(b) Purification of the MLH1-PMS1 complex. Left panel, a 7.5%
polyacrylamide gel containing 1 µg of purified MLH1–PMS1 complex
(lane 2) and molecular size markers (lane 1) was stained with
Coomassie blue. Right panel (lane 3), Nitrocellulose blot containing
50 ng of purified MLH1–PMS1 complex was probed with anti-MLH1
and anti-PMS1 antibodies.
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MLH1–PMS1 complex enhances the mismatch recognition ability of
the MSH2–MSH3 complex. (a) DNA substrates used in this study.
All the substrates share the same 32P-labeled lower strand and thus
have the same specific radioactivity. (b) Binding of DNA substrate
containing a +4 loop by purified MLH1–PMS1 complex (300 ng;
lane 6) or purified MSH2–MSH3 complex (70, 140, 210 ng, in lanes
7 to 9, respectively) or by both protein complexes together (70, 140,
210 ng of MSH2–MSH3 with 100, 200, 300 ng MLH1–PMS1 in
lanes 10 to 12, respectively). The homoduplex was incubated with
either 300 ng of MLH1–PMS1 (lane 2) or 210 ng of MSH2–MSH3
(lane 3), or a combination of these amounts of both complexes (lane
4). (c) Summary of binding of the +4 substrate shown in (b). Open
bars, binding by increasing amounts of the MSH2–MSH3 complex
as shown in lanes 7 to 9 in (b). Shaded bars, binding by increasing
amounts of both MSH2–MSH3 and MLH1–PMS1 complexes as
shown in lanes 10 to 12 in (b). (d) Binding of other mismatch
containing DNA substrates. The homoduplex and DNA substrates
containing a G/T mismatch and +1,+2, and +4 loops were incubated
with 140 ng of MSH2–MSH3 complex, with or without 200 ng of the
MLH1–PMS1 complex, as indicated. (e) Summary of the binding
data in (d). Open bars, binding by MSH2–MSH3 complex. Shaded
bars, binding by the combination of MSH2–MSH3 and MLH1–PMS1
complexes. (f) Evidence for a ternary complex. MSH2–MSH3
complex was incubated with the +4 substrate in the absence (lanes
1 and 2) or presence of MLH1-PMS1 complex (lanes 3 to 5), as
described in (d). The reaction mixtures in lanes 2, 4 and 5 were
treated with anti-MLH1 (αMLH1) or anti-PMS1 (αPMS1) antibodies
prior to electrophoresis as indicated.
Materials and methods
Polyclonal antibodies specific for MLH1 and PMS1
The affinity-purified antibodies used were raised against the carboxy-
terminal 390 amino acids of MLH1, and against residues 586–801 of
PMS1 expressed in Escherichia coli.
Yeast plasmids
The MLH1 gene from the ATG translation start codon to 204
nucleotides downstream of the TAA translation stop codon was placed
under the control of the alcohol dehydrogenase I (ADCI) promotor,
generating pMMR75 (2µ, ADCI- MLH1, TRP1). The PMS1 gene from
position –30 upstream of the ATG translation start codon to 76
nucleotides downstream of the TAA translation stop codon was fused
to the galactose-inducible GAL-PGK promotor, yielding plasmid
pMMR97 (2µ, GAL-PGK-PMS1, leu2d). These plasmids were intro-
duced into the protease-deficient yeast strain LY2. 
Purification of the MLH1–PMS1 complex
LY2 yeast, harboring plasmids pMMR75 and pMMR97, were grown
to stationary phase in complete synthetic medium lacking both
leucine and tryptophan, diluted with 10 volumes of YPD containing
1% galactose, and incubated in fermentors at 30°C for 9 h. All the
purification steps were carried out at 4°C. Cell extract was prepared
from 130 g of yeast paste using a French press. The crude lysate
was clarified by centrifugation (100,000 × g, 90 min) and the super-
natant was treated with ammonium sulfate at 0.21 g ml-1. The precipi-
tated proteins were redissolved in 240 ml of buffer K (20 mM
KH2PO4, pH 7.4, containing 0.5 mM EDTA, 1 mM dithiothreitol, and
10% glycerol) and dialysed for 4 h against 2 l buffer K. The dialysate
was clarified by centrifugation (20,000 × g, 30 min) and then applied
onto a Q Sepharose column (2.5 × 7 cm; total 34 ml matrix). The
flow-through fraction from the the Q sepharose column was loaded
onto to a column of SP Sepharose (2.5  × 6 cm; total 29 ml) which
was developed with a 100-ml gradient of 50 to 600 mM KCl in buffer
K. The peak fractions (21 ml) were pooled, dialyzed against 1 L
buffer K, and fractionated in a column of Q Sepharose (1× 4 cm; total
3 ml matrix) using a 30 ml gradient from 50–600 mM KCl. The frac-
tions containing the MLH1–PMS1 complex (6 ml) were diluted with
two volumes of 10% glycerol containing 0.01% NP-40, and then
applied onto Macro-Prep Hydroxyapatite (Type I, purchased from Bio-
Rad; 1 ml matrix packed in a HR5/5 column), which was developed
with a 20 ml gradient of 20–400 mM KH2PO4 in buffer K containing
0.01% NP-40. The peak fractions were combined, diluted with three
volumes of 10% glycerol and 0.01% NP-40, and further purified in
Mono S (HR 5/5), with a 25 ml gradient of 50–600 mM KCl in
buffer K containing 0.01% NP-40. The fractions containing the
MLH1-PMS1 complex were diluted with 3 volumes of 10% glycerol
containing 0.01% NP-40 and then fractionated in Mono Q (HR5/5)
using the same gradient for the Mono S step. The MLH1-PMS1 con-
taining fractions were concentrated in a Centricon-30 microconcen-
trator ( Amicon) and stored in small portions at –70°C.
Purification of MSH2 and MSH2–MSH3 complex
The MSH2 protein and the MSH2–MSH3 complex were purified to
near homogeneity from yeast strains genetically tailored to overproduce
these proteins, as described [7].
DNA mobility shift assay
All the DNA substrates (Figure 2a) had the same specific radioactivity
because they all share the same 32P-labeled bottom strand. The DNA
substrates (1.8 ng or 4600 c.p.m) were incubated for 30 min on ice
with different combinations of MSH2 protein (100 ng), the
MSH2–MSH3 complex (70–210 ng), and the PMS1–MLH1 complex
(100–300 ng), with 160 ng of HaeIII-digested φX174 dsDNA added as
non-specific competitor in 10 µl reaction buffer (25 mM Tris-HCl,
pH 8.0, 1 mM MgCl2, 50 mM KCl, 1 mM DTT, 50 µg ml-1 BSA and
10% glycerol). After the addition of 3 µl of gel loading buffer (50 mM
Tris-HCl, pH 7.5, 3 mM EDTA and 50% glycerol), the reaction mixtures
were subjected to electrophoresis as described [7]. For the antibody
supershifting experiment in Figure 2f, 0.5 µl of PBS (10 mM NaH2PO4,
pH 7.2, 150 mM NaCl) with or without 1.5 µg of affinity-purified anti-
MLH1 and anti-PMS1 antibodies was added at the end of the incuba-
tion. The reaction mixtures were kept at 25°C for 5 min before being
subjected to gel electrophoresis.
Supplementary material
A supplementary  figure illustrating the effects of MLH1–PMS1 on ATP
sensitivity  of MSH2–MSH3 binding and on binding of MSH2 alone is
also published with this paper on the internet.
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